Sorry - There were no pages found that contain that search phrase.
 |
 |
 |
 |
|
 |
Showing Treatment 1 to 25 of 136 Next 25 |
 |
Location |
 |
Last Updated |
 |
 |
 |
Details |
 |
Effect of NovoTTF-100A Together With Temozolomide in Newly Diagnosed Glioblastoma Multiforme (GBM) |
 |
San Diego, CA USA |
 |
09/30/2009 |
 |
 |
 |
 |
 |
Details |
 |
Study of Fractionated Stereotactic Radiosurgery to Treat Large Brain Metastases |
 |
Stanford, CA USA |
 |
09/01/2009 |
 |
 |
 |
Details |
 |
Phase 1 Study of Azixa (MPC-6827) and Carboplatin in Recurrent/Relapsed Glioblastoma Multiforme |
 |
Los Angeles, CA USA |
 |
08/11/2009 |
 |
 |
 |
 |
 |
Details |
 |
Phase 2 Study of Azixa (MPC-6827) for the Treatment of Patients With Recurrent Glioblastoma Multiforme |
 |
Los Angeles, CA USA |
 |
08/11/2009 |
 |
 |
 |
Details |
 |
Phase 2 Study of Azixa (MPC-6827) for the Treatment of Patients With Recurrent Glioblastoma Multiforme |
 |
Stanford, CA USA |
 |
08/11/2009 |
 |
 |
 |
 |
 |
Details |
 |
ABTC07-01-Phase I Trial of Aflibercept (VEGF Trap) with Radiation Therapy and Concomitant and Adjuvant
Temozolomide in Patients with Malignant Glioma |
 |
San Francisco, CA USA |
 |
07/07/2009 |
 |
 |
 |
Details |
 |
PHASE II, single-arm, open-label investigation of HSPPC-96 vaccine with concurrent temozolomide in patients with newly diagnosed Glioblastoma Multiforme |
 |
San Francisco, CA USA |
 |
07/07/2009 |
 |
 |
 |
 |
 |
Details |
 |
A Phase 2 Study of XL184 in Subjects with Progressive or Recurrent Glioblastoma Multiforme in First or Second Relapse |
 |
San Francisco, CA USA |
 |
06/29/2009 |
 |
 |
 |
Details |
 |
Phase II Trial of RAD001 in Patients with Recurrent Low Grade Glioma |
 |
San Francisco, CA USA |
 |
04/06/2009 |
 |
 |
 |
 |
 |
Details |
 |
A Phase I Trial of Nanoliposomal CPT-11 (NL CPT-11) in Patients With Recurrent High-Grade Gliomas |
 |
San Francisco, CA USA |
 |
04/06/2009 |
 |
 |
 |
Details |
 |
Study of a Drug [DCVax®-Brain] to Treat Newly Diagnosed GBM Brain Cancer |
 |
Los Angeles, CA USA |
 |
03/15/2009 |
 |
 |
 |
 |
 |
Details |
 |
The GLASS-ART Trial: A Phase III Randomized Study of Neuradiab in Combination With External Beam Radiation and Temozolomide Versus External Beam Radiation and Temozolomide in Patients With Newly Diagnosed Glioblastoma Multiforme |
 |
Los Angeles, CA USA |
 |
03/04/2009 |
 |
 |
 |
Details |
 |
Phase II Study of CDX-110 in Patients With Glioblastoma Multiforme (GBM) (ACT III) |
 |
Los Angeles, CA USA |
 |
01/31/2009 |
 |
 |
 |
 |
 |
Details |
 |
Phase II Study of CDX-110 in Patients With Glioblastoma Multiforme (GBM) (ACT III) |
 |
San Francisco, CA USA |
 |
01/31/2009 |
 |
 |
 |
Details |
 |
Phase II Study of CDX-110 in Patients With Glioblastoma Multiforme (GBM) (ACT III) |
 |
Los Angeles, CA USA |
 |
01/31/2009 |
 |
 |
 |
 |
 |
Details |
 |
Phase II Study of CDX-110 in Patients With Glioblastoma Multiforme (GBM) (ACT III) |
 |
Palo Alto, CA USA |
 |
01/31/2009 |
 |
 |
 |
Details |
 |
Phase II Study of CDX-110 in Patients With Glioblastoma Multiforme (GBM) (ACT III) |
 |
San Francisco, CA USA |
 |
01/31/2009 |
 |
 |
 |
 |
 |
Details |
 |
Phase II Study of CDX-110 in Patients With Glioblastoma Multiforme (GBM) (ACT III) |
 |
Orange, CA USA |
 |
01/31/2009 |
 |
 |
 |
Details |
 |
NABTC05-02 - Phase I/II Studies of BAY 43-9006 (sorafenib) in Combination with OSI-774 (erlotinib), R115777 (tipifarnib) or CCI-779 (temsirolimus) in Patients with Recurrent Glioblastoma Multiforme or Gliosarcoma. |
 |
San Francisco, CA USA |
 |
01/09/2009 |
 |
 |
 |
 |
 |
Details |
 |
A Phase II study of Bevacizumab (Avastin?) plus Temodar and Tarceva during and after Radiation Therapy in patients with newly diagnosed Glioblastoma or Gliosarcoma |
 |
San Francisco, CA USA |
 |
01/09/2009 |
 |
 |
 |
Details |
 |
Quality of Life in Patients with Brain Tumors, Skull Base Tumors & Pituitary Adenomas Undergoing Surgical Resection |
 |
Santa Monica, CA USA |
 |
11/29/2008 |
 |
 |
 |
 |
 |
Details |
 |
Bevacizumab (Avastin) and Irinotecan (CPT-11) in Treating Young Patients With Recurrent, Progressive, or Refractory Glioma, Medulloblastoma, Ependymoma, or Low Grade Glioma
|
 |
San Francisco, CA USA |
 |
11/08/2008 |
 |
 |
 |
Details |
 |
Phase I Trial of Aflibercept (VEGF Trap)with Radiation Therapy and Concomitant and Adjuvant Temozolomide in Patients With Malignant Gliomas |
 |
Los Angeles, CA USA |
 |
10/27/2008 |
 |
 |
 |
 |
 |
Details |
 |
Phase I Trial of Aflibercept (VEGF Trap)with Radiation Therapy and Concomitant and Adjuvant Temozolomide in Patients With Malignant Gliomas |
 |
San Francisco, CA USA |
 |
10/27/2008 |
 |
 |
 |
Details |
 |
Phase I/II Studies of BAY 43-9006 (Sorafenib) in Combination With OSI-774 (Erlotinib), R115777 (Tipifarnib) or CCI-779 (Temsirolimus) in Patients With Recurrent Glioblastoma Multiforme or Gliosarcoma |
 |
Los Angeles, CA USA |
 |
04/15/2008 |
 |
 |
 |
 |
 |